2020
DOI: 10.1080/08820139.2020.1832115
|View full text |Cite
|
Sign up to set email alerts
|

Tumor Necrosis Factor-alpha (TNF-α) −238 G/A Polymorphism Is Associated with the Treatment Resistance and Attempted Suicide in Schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 50 publications
0
10
0
Order By: Relevance
“…Some evidence shows that there is an association between schizophrenia and allele A or G of TNF-α − 308 G/A [ 242 ] as well as Hasan et al demonstrated that TNF-α − 238 G/A and − 308 G/A polymorphisms are not associated with schizophrenia but TNF-α − 238 G/A polymorphism may be related to treatment resistance and attempted suicide in patients with schizophrenia. In particular, the patients that carry the GG genotype of TNF-α − 238 G/A seem to have a higher risk of treatment resistance [ 243 ].…”
Section: Genetic Findingsmentioning
confidence: 99%
“…Some evidence shows that there is an association between schizophrenia and allele A or G of TNF-α − 308 G/A [ 242 ] as well as Hasan et al demonstrated that TNF-α − 238 G/A and − 308 G/A polymorphisms are not associated with schizophrenia but TNF-α − 238 G/A polymorphism may be related to treatment resistance and attempted suicide in patients with schizophrenia. In particular, the patients that carry the GG genotype of TNF-α − 238 G/A seem to have a higher risk of treatment resistance [ 243 ].…”
Section: Genetic Findingsmentioning
confidence: 99%
“…Lastly, rs1800629 and rs361525 (–238 G/A) polymorphisms have been the subject of one study in patients with schizophrenia with or without a history of SA. The distribution of rs361525 genotype, but not that of rs1800629, was significantly different in SAs compared to individuals with no history of SB ( 44 ).…”
Section: Resultsmentioning
confidence: 79%
“…Then, the Structured Clinical Interview for DSM-IV Axis-I Disorders (SCID-I) was administered to verify the patients’ diagnosis. 20 , 21 The Positive and Negative Symptoms Scale (PANSS) 22 , 23 was applied for patients with SCZ, while the Hamilton Depression Rating Scale (HAM-D) 24 , 25 and the Young Mania Rating Scale 26 , 27 were for evaluating BD patients concerning the severity of symptoms. We assessed the impairment of insight in SCZ with the Schedule for Assessing the Three Components of Insight (SATCI).…”
Section: Methodsmentioning
confidence: 99%